GLOBEIMMUNE INC Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GBIM and buy or sell other stocks, ETFs, and their options commission-free!About GBIM
GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform.
CEOTimothy C. Rodell, Jr., MD
CEOTimothy C. Rodell, Jr., MD
Employees3
Employees3
HeadquartersLouisville, Colorado
HeadquartersLouisville, Colorado
Founded1995
Founded1995
Employees3
Employees3
GBIM Key Statistics
Market cap575.20
Market cap575.20
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume100.00
Average volume100.00
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0005
52 Week high$0.0005
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
The current GLOBEIMMUNE INC Common Stock(GBIM) stock price is $0.00, with a market capitalization of 575.2.
GLOBEIMMUNE INC Common Stock(GBIM) stock opened on 2026-04-22 at —. The price climbed to — and dipped to —.
The GLOBEIMMUNE INC Common Stock(GBIM)'s current trading volume is 0, compared to an average daily volume of 100.
In the last year, GLOBEIMMUNE INC Common Stock(GBIM) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
In the last year, GLOBEIMMUNE INC Common Stock(GBIM) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.